Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H. pylori-associated chronic idiopathic thrombocytopenic purpura.
about
Current views of the relationship between Helicobacter pylori and Henoch-Schonlein purpura in childrenHelicobacter pylori Eradication in Patients with Immune Thrombocytopenic Purpura: A Review and the Role of BiogeographyPiecing together the humoral and cellular mechanisms of immune thrombocytopeniaThe pathogenesis of immune thrombocytopaenic purpuraThrombocytopenia and infections.Effect of Helicobacter pylori eradication in patients with chronic idiopathic thrombocytopenic purpura-a randomized controlled trial.Helicobacter pylori-associated immune thrombocytopenia.Platelet activation in Helicobacter pylori-associated idiopathic thrombocytopenic purpura: eradication reduces platelet activation but seldom improves platelet counts.Helicobacter pylori eradication reduces platelet count in patients without idiopathic thrombocytopenic purpura.Helicobacter pylori-associated chronic idiopathic thrombocytopenic purpura and low molecular weight H. pylori proteins.Proof of an association between Helicobacter pylori and idiopathic thrombocytopenic purpura in Latin America.The long-term efficacy of Helicobacter pylori eradication therapy in patients with idiopathic thrombocytopenic purpura.Outcome of immunosuppressive therapy with Helicobacter pylori eradication therapy in patients with chronic idiopathic thrombocytopenic purpuraHelicobacter pylori eradication shifts monocyte Fcgamma receptor balance toward inhibitory FcgammaRIIB in immune thrombocytopenic purpura patients.Pathobiology of secondary immune thrombocytopenia.The ITP syndrome: pathogenic and clinical diversity.Platelet count response to H. pylori treatment in patients with immune thrombocytopenic purpura with and without H. pylori infection: a systematic review.Effect of eradication of Helicobacter pylori in children with chronic immune thrombocytopenia: a prospective, controlled, multicenter study.Consequences of Helicobacter pylori infection in children.Pathophysiology and management of chronic immune thrombocytopenia: focusing on what matters.Pathophysiology and therapeutic options in primary immune thrombocytopenia.Development of corpus atrophic gastritis may be associated with Helicobacter pylori-related idiopathic thrombocytopenic purpura.Immune thrombocytopenia: no longer 'idiopathic'.Circulating plasmacytoid dendritic cells in patients with primary and Helicobacter pylori-associated immune thrombocytopenia.Extragastrointestinal manifestations of Helicobacter pylori infection: facts or myth? A critical review.H pylori-induced thrombocytopenia in a Caucasian female: a case report.Platelet Count Response to Helicobacter pylori Eradication in Iranian Patients with Idiopathic Thrombocytopenic Purpura.Pathophysiology and management of primary immune thrombocytopenia.Poor platelet Count Response to Helicobacter Pylori Eradication in Patients with Severe Idiopathic Thrombocytopenic Purpura.Helicobacter pylori-associated immune thrombocytopenia: clinical features and pathogenic mechanisms.Helicobacter pylori infection and extragastric disorders in children: a critical updateImmune thrombocytopaenic purpura: an autoimmune cross-link between infections and vaccines.Helicobacter pylori infection & immune thrombocytopenic purpura in children and adolescents: A randomized controlled trial.Helicobacter pylori eradication in patients with chronic immune thrombocytopenic purpura.From prednisone to pylori: a case of Helicobacter pylori-induced chronic immune thrombocytopeniaHelicobacter pylori infection in Mongolian gerbils does not initiate hematological diseasesCytokine profile of patients with chronic immune thrombocytopenia affects platelet count recovery after Helicobacter pylori eradication.Hematologic manifestations of Helicobacter pylori infectionImmune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported cases.Efficacy of Helicobacter pylori eradication for the 1st line treatment of immune thrombocytopenia patients with moderate thrombocytopenia.
P2860
Q26766952-B8C9CBA6-DB73-44A8-98FA-E3F3C890CCD2Q26865062-1C181ADA-AB17-4555-AB2A-B67986A4A6A1Q27024841-9DE4E8CA-86EE-4E37-A10D-ACE54FC1995CQ28236898-79657DA0-2FD9-495F-941B-21354F093D38Q30240119-85AB94B6-7CEB-4666-86EE-0EA52F5B660FQ33366597-DEA68B4A-99C1-427C-BD44-6CACBDC7B421Q33369972-4638451A-B747-44BB-B226-64F8C9574E09Q33371787-066D92B0-D260-4578-A62A-EF3DB3A06571Q33374586-20994E7D-30EF-4308-A55C-8FD410825EFDQ33375044-A582E1E2-08C6-4B8E-A99E-2099864CD5F2Q33375206-67C85777-F797-435C-96AB-CCB2E5A43994Q33375521-48921F42-3B72-44B8-97FD-E7AA83259ED9Q33380113-DF2B6DD1-022A-4D61-9409-DB609A9C666CQ33380490-C642B06F-1C47-4215-8025-120B27288590Q33383468-0E8DA596-F762-4620-A54D-1D0A42350149Q33384235-619758FC-EC42-4636-A37F-FF82B5871A09Q33384729-76F2F9E6-CE43-428D-985E-866C4E613AB6Q33391827-67AAA58A-3B83-415B-98B3-78986108E870Q33392675-C1B320CA-9071-4FE0-9D89-207DE8B9E5DFQ33392868-56C08F0A-8312-4995-B7DD-8FEE9655BAD8Q33393732-0C1D5E0B-FB73-4F27-8F22-FD656A137EEFQ33395396-AF199D74-5C4C-4A50-9D6D-9076A0C4E3A7Q33395624-B5E4128F-2234-416E-ABAE-DB6656D79703Q33399044-2AC9429D-3E93-451A-B088-4605A8178379Q33401864-A11BF217-02E2-4758-9EF9-EAB4DC9CEEA6Q33402328-4612EA49-6889-4355-BCA3-F54FBD90218BQ33403282-058FD1EA-2195-4B46-824E-C03E50AD0EDDQ33407942-55FBDEB9-6CB5-4DC4-B678-36289494B2EFQ33413202-A361F639-7DB1-43D4-BEA9-2C21FEEA4E65Q33413543-AD4EE848-D11A-494F-A6D5-E34505795298Q33413620-ECA8800E-E83F-47D1-B75A-804EF8A40097Q33414858-13554F35-DF74-474A-BE85-E357D7FC08DFQ33415361-580B9DC5-AAC1-4B4E-8CF2-04B50D8257C9Q33416003-646486F5-4CA3-4630-B950-32F98DF662D0Q33416507-3B5DDDE6-99BB-475C-B4A7-DACFE6C05627Q33417717-CF95E4C5-0EC1-42F1-88E4-D2D9EB6608F9Q33417859-52D9A3D2-4A1F-4765-AEDB-839D54851DC8Q33417972-946DACB3-18A1-4AB2-9E46-63901B9F36E5Q33418883-42270BBB-198C-4840-8191-8A6DE4E48C07Q33419309-EB340F49-90AF-4A63-A79D-AC243A8600F7
P2860
Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H. pylori-associated chronic idiopathic thrombocytopenic purpura.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Molecular mimicry by Helicobac ...... thic thrombocytopenic purpura.
@ast
Molecular mimicry by Helicobac ...... thic thrombocytopenic purpura.
@en
type
label
Molecular mimicry by Helicobac ...... thic thrombocytopenic purpura.
@ast
Molecular mimicry by Helicobac ...... thic thrombocytopenic purpura.
@en
prefLabel
Molecular mimicry by Helicobac ...... thic thrombocytopenic purpura.
@ast
Molecular mimicry by Helicobac ...... thic thrombocytopenic purpura.
@en
P2093
P2860
P1476
Molecular mimicry by Helicobac ...... thic thrombocytopenic purpura.
@en
P2093
Kenji Shinohara
Koichi Ariyoshi
Masashi Okubo
Mutsunori Shirai
Ryouhei Nawata
Toshiaki Yujiri
Yasuhiko Fujii
Yoshitomo Oka
Yukinori Nakamura
Yukio Tanizawa
P2860
P356
10.1046/J.1365-2141.2003.04735.X
P407
P577
2004-01-01T00:00:00Z